VP-001

· PYC Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VP-001, covering 2025-12-02 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) [Phase 1]